Sherlock Biosciences, Inc. Sustainability Profile
Sherlock Biosciences, Inc., a pioneering force in the biotechnology sector, is headquartered in the United States. Founded in 2019, the company has rapidly established itself as a leader in the development of CRISPR-based diagnostic tools and solutions. With a focus on revolutionising molecular diagnostics, Sherlock Biosciences offers unique products that leverage advanced CRISPR technology for rapid and accurate detection of pathogens and genetic mutations. The company’s flagship offerings, including the Sherlock™ platform, stand out for their precision and ease of use, catering to both clinical and research applications. Notable achievements include significant partnerships and collaborations that enhance its market position, making Sherlock Biosciences a key player in the evolving landscape of healthcare innovation. With a commitment to improving global health outcomes, the company continues to push the boundaries of what is possible in diagnostics.
DitchCarbon Score
How does Sherlock Biosciences, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Sherlock Biosciences, Inc.'s score of 25 is lower than 51% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Sherlock Biosciences, Inc.'s reported carbon emissions
Sherlock Biosciences, Inc., headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. The company has not established any documented reduction targets or climate pledges, which suggests a lack of formalised commitments towards carbon neutrality or emissions reduction. However, it is important to note that emissions data may be cascaded from its parent company, OraSure Technologies, Inc., at a current subsidiary level. This means that while Sherlock Biosciences may not have its own emissions data, it could potentially align with the sustainability initiatives and targets set by OraSure Technologies. As of now, without specific emissions data or reduction targets, Sherlock Biosciences' climate commitments remain unclear. The company may benefit from adopting industry-standard climate strategies to enhance its environmental impact and align with broader corporate sustainability goals.
How Carbon Intensive is Sherlock Biosciences, Inc.'s Industry?
How Carbon Intensive is Sherlock Biosciences, Inc.'s Location?
Sherlock Biosciences, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Sherlock Biosciences, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
